연구동향 분석

Routine Angiographic Follow-Up versus Clinical Follow-Up after Percutaneous Coronary Intervention in Acute Myocardial Infarction

나승운 김용훈 허애영 최병걸 심민석 최세연 변재경 Hu Li 김우현 강준혁 최자연 박은진 박성훈 이선기 나진오 최철웅 임홍의 김응주 박창규 서홍석 오동주 2017년

논문상세정보
인용/피인용

' Routine Angiographic Follow-Up versus Clinical Follow-Up after Percutaneous Coronary Intervention in Acute Myocardial Infarction' 의 참고문헌

  • Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry
    Lasala JM Catheter Cardiovasc Interv 72 433-445 [2008]
  • The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of “oculostenotic”reintervention in patients with intermediate lesions
    Uchida T JACC Cardiovasc Interv 3 403-411 [2010]
  • Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
    Moses JW N Engl J Med 349 1315-1323 [2003]
  • Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators
    Hochman JS N Engl J Med 341 226-232 [1999]
  • Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial
    Stone GW J Am Coll Cardiol 56 1597-1604 [2010]
  • Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies
    Kirtane AJ Circulation 119 3198-3206 [2009]
  • Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up
    Asakura M Circulation 97 2003-2006 [1998]
  • Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study
    Pijls NH J Am Coll Cardiol 49 2105-2111 [2007]
  • O’Shaughnessy C, et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial
    Pinto DS J Am Coll Cardiol 48 32-36 [2006]
  • Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching
    홍명기 Yonsei Medical Journal 58 2 290-295 [2017]
  • Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for STsegment elevation myocardial infarction
    Mindrescu C J Interv Cardiol 26 319-324 [2013]
  • Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years
    Lansky AJ Am J Cardiol 110 21-29 [2012]
  • Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
    Silber S Eur Heart J 26 804-847 [2005]
  • Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials
    De Luca G Int J Cardiol 133 213-222 [2009]
  • Coronary stents: current status
    Garg S J Am Coll Cardiol 56 10 Suppl S1-S42 [2010]
  • Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials
    Cutlip DE J Am Coll Cardiol 40 2082-2089 [2002]
  • Changes in the Practice of Coronary Revascularization between 2006 and 2010 in the Republic of Korea
    최윤정 Yonsei Medical Journal 56 4 895-903 [2015]
  • A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
    Stone GW N Engl J Med 350 221-231 [2004]
  • 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines
    King SB 3rd J Am Coll Cardiol 51 172-209 [2008]